More positive safety results for NewLink/Merck Ebola vaccine

Yet another study has shown an experimental Ebola vaccine from NewLink Genetics and its partner Merck to be safe, with the product eliciting robust antibody responses in all 40 of the healthy adults who received it at Walter Reed Army Institute of Research in Silver Spring, Maryland and at the National Institutes of Health (NIH) in Bethesda, Maryland.